The influence of 2-chlorodeoxyadenosine (2-CdA) alone and in combination with cyclophosphamide or methotrexate on normal and leukemic hematopoiesis.
Góra-Tybor
J
J
Department of Pharmacology, Medical University of Lodz.
Robak
T
T
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D017338:Cladribine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007939:Leukemia L1210 / Q000097:blood* / Q000188:drug therapy; D007941:Leukemia P388 / Q000097:blood* / Q000188:drug therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000473:pathology; D051379:Mice
D017338:Cladribine; D003520:Cyclophosphamide